Induction of remission is difficult due to frequent relapse during tapering steroids in Korean patients with polymyalgia rheumatica

Journal of Korean Medical Science

Volumn 27, Issue 1, 2012, Pages 22-26

  Kim, Hyoun Ah ^a,b   Lee, Jisoo ^c   Ha, You Jung ^d   Kim, Sang Hyon ^e   Lee, Chan Hee ^f   Choi, Hyo Jin ^g   Baek, Han Joo ^g   Lim, Mie Jin ^h   Park, Won ^h   Choi, Sungiae ⁱ   Hong, Yeon Sik ^j   Lee, Yoo Hyun ^k   Koh, Bo Ram ^a,b   Suh, Chang Hee ^a,b  

^a Ajou University School of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

^d Kwandong University College of Medicine   (South Korea)

^e Dongsan Medical Center   (South Korea)

^f National Health Insurance Corporation   (South Korea)

^g Gachon University College of Medicine   (South Korea)

^h Inha University Hospital   (South Korea)

ⁱ Korea University College of Medicine   (South Korea)

^j Bupyeong gu   (South Korea)

^k Madisarang Rheumatology Clinic   (South Korea)

more..

Author keywords

Polymyalgia rheumatica; Prognosis; Remission; Steroids; Symptoms; Treatment

Indexed keywords

ANTIINFLAMMATORY AGENT; STEROID;

AGED; ARTICLE; COHORT ANALYSIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; SEASON; SOUTH KOREA;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BLOOD SEDIMENTATION; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; PROGNOSIS; RECURRENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SEASONS; STEROIDS;

EID: 84863125596     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2012.27.1.22     Document Type: Article

References (30)

1. Cimmino MA, Zaccaria A. Epidemiology of polymyalgia rheumatica. Clin Exp Rheumatol 2000; 18: S9-11.
2. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97: 672-80.
3. Michet CJ, Matteson EL. Polymyalgia rheumatica. BMJ 2008; 336: 765-9.
4. Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis 2006; 65: 1093-8.
5. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giantcell arteritis. Lancet 2008; 372: 234-45.
6. Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979; 38: 434-9.
7. Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984; 13: 322-8.
8. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica. Best Pract Res Clin Rheumatol 2004; 18: 705-22.
9. van der Veen MJ, Dinant HJ, van Booma-Frankfort C, van Albada-Kuipers GA, Bijlsma JW. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? Ann Rheum Dis 1996; 55: 218-23.
10. Ferraccioli G, Salaffi F, De Vita S, Casatta L, Bartoli E. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J Rheumatol 1996; 23: 624-8.
11. Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C, Montecucco C; Systemic Vasculitis Study Group of the Italian Society for Rheumatology. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2004; 141: 493-500.
12. Salvarani C, Cantini F, Niccoli L, Catanoso MG, Macchioni P, Pulsatelli L, Padula A, Olivieri I, Boiardi L. Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study. J Rheumatol 2003; 30: 760-3.
13. Migliore A, Massafra U, Carloni E, Padalino C, Martin S, Lasaracina F, Dibiase N, Alimonti A, Granata M. TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report. Eur Rev Med Pharmacol Sci 2005; 9: 373-8.
14. Catanoso MG, Macchioni P, Boiardi L, Pipitone N, Salvarani C. Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study. Arthritis Rheum 2007; 57: 1514-9.
15. Mori S, Koga Y, Ito K. Clinical characteristics of polymyalgia rheumatica in Japanese patients: evidence of synovitis and extracapsular inflammatory changes by fat suppression magnetic resonance imaging. Mod Rheumatol 2007; 17: 369-75.
16. Mackie SL, Hensor EM, Haugeberg G, Bhakta B, Pease CT. Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study. Rheumatology (Oxford) 2010; 49: 716-22.
17. Li WL, Lo Y, Leung MH, Wong WS, Mok MY. The clinical course of polymyalgia rheumatica in Chinese. Clin Rheumatol 2010; 29: 199-203.
18. Pease CT, Haugeberg G, Montague B, Hensor EM, Bhakta BB, Thomson W, Ollier WE, Morgan AW. Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study. Rheumatology (Oxford) 2009; 48: 123-7.
19. Salvarani C, Cantini F, Macchioni P, Olivieri I, Niccoli L, Padula A, Boiardi L. Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum 1998; 41: 1221-6.
20. Hutchings A, Hollywood J, Lamping DL, Pease CT, Chakravarty K, Silverman B, Choy EH, Scott DG, Hazleman BL, Bourke B, Gendi N, Dasgupta B. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica. Arthritis Rheum 2007; 57: 803-9.
21. Bird HA, Leeb BF, Montecucco CM, Misiuniene N, Nesher G, Pai S, Pease C, Rovensky J, Rozman B. A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. Ann Rheum Dis 2005; 64: 626-9.
22. Kobayashi S, Yano T, Matsumoto Y, Numano F, Nobuyuki N, Yasuda K, Yutani C, Nakayama T, Tamakoshi A, Kawamura T, Ohno Y, Inaba Y, Hashimoto H. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first gonvernment-supported nationwide survey. Arthritis Rheum 2003; 49: 594-8.
23. Mertens JC, Willemsen G, Van Saase JL, Bolk JH, Dijkmans BA. Polymyalgia rheumatica and temporal arteritis: a retrospective study of 111 patients. Clin Rheumatol 1995; 14: 650-5.
24. Cimmino MA, Caporali R, Montecucco CM, Rovida S, Baratelli E, Broggini M. A seasonal pattern in the onset of polymyalgia rheumatica. Ann Rheum Dis 1990; 49: 521-3.
25. Petursdottir V, Johansson H, Nordborg E, Nordborg C. The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology (Oxford) 1999; 38: 1208-12.
26. Peris P. Polymyalgia rheumatica is not seasonal in pattern and is unrelated to parvovirus b19 infection. J Rheumatol 2003; 30: 2624-6.
27. Narváez J, Clavaguera MT, Nolla-Solé JM, Valverde-Garcia J, Roig-Escofet D. Lack of association between infection and onset of polymyalgia rheumatica. J Rheumatol 2000; 27: 953-7.
28. Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE. Relapse in a population based cohort of patients with polymyalgia rheumatica. J Rheumatol 2005; 32: 65-73.
29. Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino M, Gerli R, Catanoso MG, Boiardi L, Cantini F, Klersy C, Hunder GG. Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med 2007; 146: 631-9.
30. Salvarani C, Cantini F, Niccoli L, Macchioni P, Consonni D, Bajocchi G, Vinceti M, Catanoso MG, Pulsatelli L, Meliconi R, Boiardi L. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum 2005; 53: 33-8.